Large-Scale Purification and Characterization of Malaria Vaccine Candidate Antigen Pvs25H for Use in Clinical Trials

This publication has 14 references indexed in Scilit:

• The neglected burden of Plasmodium vivax malaria
  The American Journal of Tropical Medicine and Hygiene, 2001
• Antibodies to Malaria Vaccine Candidates Pvs25 and Pvs28 Completely Block the Ability ofPlasmodium vivaxTo Infect Mosquitoes
  Infection and Immunity, 2000
• Structural conformers produced during malaria vaccine production in yeast
  Yeast, 2000
• Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-119) and T helper epitopes of tetanus toxoid
  Vaccine, 1999
• Sequence Polymorphism in Two Novel Plasmodium vivax Ookinete Surface Proteins, Pvs25 and Pvs28, That Are Malaria Transmission-blocking Vaccine Candidates
  Molecular Medicine, 1998
• PATHWAYS AND STRATEGIES FOR DEVELOPING A MALARIA BLOOD-STAGE VACCINE
  Annual Review of Immunology, 1998
• Transmission-blocking vaccines: Uses and current status of development
  International Journal for Parasitology, 1997
• Insecticide Resistance Issues in Vector-Borne Disease Control
  The American Journal of Tropical Medicine and Hygiene, 1994
• PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?
  The Lancet, 1989
• CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN THAILAND
  The Lancet, 1965